Quantcast

Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...




Untitled Document

Biotricity, Inc. (BTCY)

Biotricity, Inc. is a medical diagnostic and consumer healthcare technology company listed on the OTC Markets Group's OTCQB. The company's commitment is to deliver biometric remote monitoring solutions. Biotricity delivers these solutions to the medical and consumer markets. This includes diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity has its corporate off ice in Redwood City, California.

Biotricity's vision is putting health management into the hands of the individual. It is working to support the self-management of critical and chronic conditions with the use of unique solutions to ease the growing burden on the healthcare system. Biotricity's Research and Development (R&D) continues to center on the preventative healthcare market.

Biotricity has created two ECG monitoring devices. The design of these is to improve upon the tools and devices presently available in today's market. For Physicians, the company has its Bioflux. This is a medical technology solution for physicians to test and diagnose patients, and benefit from an innovative system, which provides ongoing active monitoring for up to 30 consecutive days.

For Consumers, Biotricity has its Biolife. This is a preventative care solution. It leverages the expertise gained from the company's Bioflux. The design of it is to help individuals track their progress in real-time so they can stay motivated to make lifestyle changes. Biolife helps users make lifestyle changes through uniting medically relevant ECG data with social media interactivity and a lifestyle log.

Bioflux comprises an ECG monitoring device, software, and access to a monitoring lab. The Bioflux software component is an acquisition that is already Food and Drug Administration (FDA) cleared. It is a standard for ECG monitoring in cardiac clinics and hospitals.

Biotricity has partnered with Global to Local (G2L). This collaboration between Biotricity and G2L will first center on building distinct solutions for outcome measurements for individuals suffering from chronic disease. G2L is an organization devoted to providing programs that improve individual and community health outcomes, expands access to healthcare services, and empowers economic development in the most varied and underserved communities.

Recently, Biotricity announced that the company received its 510(k) clearance for its Bioflux device with the U.S. Food and Drug Administration (FDA). This latest 510(k) is the final FDA requirement required for Biotricity to bring to market Bioflux in the United States.

Biotricity commenced its first production run of the Bioflux solution. Large scale manufacturing is in place. Biotricity is set to start mass production.

Biotricity also recently announced that it began extending the capabilities of its remote patient monitoring (RPM) platform with artificial intelligence (AI). This is to differentiate itself within the increasing remote monitoring marketplace. Biotricity is working with a proof of concept version of its RPM hardware with embedded AI.

Biotricity also recently announced that it began extending the capabilities of its remote patient monitoring (RPM) platform with artificial intelligence (AI). This is to differentiate itself within the increasing remote monitoring marketplace. Biotricity is working with a proof of concept version of its RPM hardware with embedded AI.

 

 

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue